The TCGA lung cancer patient dataset revealed an upregulation of DDR1 in patients with a KRAS or EGFR mutation, but not in those with STK11/LKB1 or TP53 mutations (Supplementary Figure S1). This evidence concerns the gene DDR1 and lung carcinoma.